448 related articles for article (PubMed ID: 24463503)
1. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
[TBL] [Abstract][Full Text] [Related]
3. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J
Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
6. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
7. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene.
Zheng JN; Pei DS; Sun FH; Zhang BF; Liu XY; Gu JF; Liu YH; Hu XL; Mao LJ; Wen RM; Liu JJ; Li W
Cancer Biol Ther; 2009 Jan; 8(1):84-91. PubMed ID: 19029834
[TBL] [Abstract][Full Text] [Related]
9. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
10. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.
Machitani M; Sakurai F; Wakabayashi K; Tachibana M; Fujiwara T; Mizuguchi H
Mol Cancer Ther; 2017 Jan; 16(1):251-259. PubMed ID: 27760834
[TBL] [Abstract][Full Text] [Related]
13. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
[TBL] [Abstract][Full Text] [Related]
14. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
15. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene].
Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340
[TBL] [Abstract][Full Text] [Related]
16. A novel oncolytic adenovirus based on simian adenovirus serotype 24.
Cheng T; Song Y; Zhang Y; Zhang C; Yin J; Chi Y; Zhou D
Oncotarget; 2017 Apr; 8(16):26871-26885. PubMed ID: 28460470
[TBL] [Abstract][Full Text] [Related]
17. Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.
Doloff JC; Jounaidi Y; Waxman DJ
Cancer Gene Ther; 2011 Mar; 18(3):153-66. PubMed ID: 20865021
[TBL] [Abstract][Full Text] [Related]
18. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
Bilsland AE; Merron A; Vassaux G; Keith WN
Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.
Sato D; Kurihara Y; Kondo S; Shirota T; Urata Y; Fujiwara T; Shintani S
Oncol Rep; 2013 Dec; 30(6):2659-64. PubMed ID: 24065118
[TBL] [Abstract][Full Text] [Related]
20. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
